Target Name: MCHR2
NCBI ID: G84539
Review Report on MCHR2 Target / Biomarker Content of Review Report on MCHR2 Target / Biomarker
MCHR2
Other Name(s): MCH2R | GPRv17 | G protein-coupled receptor slt | SLT | MCH receptor 2 | MCH-2R | MCHR-2 | G-protein coupled receptor 145 | melanin-concentrating hormone 2 | GPR145 | MCH2 | MCHR2_HUMAN | Melanin concentrating hormone receptor 2, transcript variant 2 | G protein-coupled receptor 145 | Melanin-concentrating hormone receptor 2 | MCH-R2 | melanin concentrating hormone receptor 2 | Melanin-concentrating hormone 2 | MCHR2 variant 2

MCHR2: A Protein Involved in Neurotransmission and Disease

MCHR2 (MCH2R) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of G-coupled receptors, which are a family of transmembrane proteins that play a crucial role in cellular signaling.

MCHR2 is involved in a wide range of physiological processes in the body, including drug response, pain perception, and neurodegeneration. It is also a potential drug target, which means that scientists are studying it as a possible target for new treatments.

One of the key functions of MCHR2 is its role in neurotransmission. MCHR2 is a critical receptor for the neurotransmitter GABA, which is involved in a wide range of brain functions, including sleep, wakefulness, and anxiety. MCHR2 is also involved in the regulation of pain perception, and has been shown to play a role in the development of chronic pain conditions.

In addition to its role in neurotransmission, MCHR2 is also involved in a number of other processes in the body. For example, it is involved in the regulation of ion channels, which are responsible for the flow of electrical signals through cells. It is also involved in the regulation of gene expression, which is the process by which cells express a wide range of proteins.

MCHR2 is also of interest as a potential drug target because of its involvement in a number of diseases, including cancer, neurodegenerative diseases, and chronic pain conditions. For example, studies have shown that MCHR2 is involved in the development of neurofibrillary tangles, which are a hallmark of Alzheimer's disease, and that it is involved in the development of chronic pain conditions.

In conclusion, MCHR2 is a protein that is expressed in various tissues of the body and is involved in a wide range of physiological processes, including neurotransmission, ion channel regulation, and gene expression. It is also involved in the development of a number of diseases, including cancer and chronic pain conditions. As a result, MCHR2 is a potential drug target for new treatments. Further research is needed to fully understand the role of MCHR2 in these processes and to develop new treatments based on its properties.

Protein Name: Melanin Concentrating Hormone Receptor 2

Functions: Receptor for melanin-concentrating hormone, coupled to G proteins that activate phosphoinositide hydrolysis

The "MCHR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MCHR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MCHR2-AS1 | MCIDAS | MCL1 | MCM10 | MCM2 | MCM3 | MCM3AP | MCM3AP-AS1 | MCM4 | MCM5 | MCM6 | MCM7 | MCM8 | MCM8-MCM9 complex | MCM9 | MCMBP | MCMDC2 | MCOLN1 | MCOLN2 | MCOLN3 | MCPH1 | MCPH1-AS1 | MCPH1-DT | MCRIP1 | MCRIP2 | MCRS1 | MCTP1 | MCTP2 | MCTS1 | MCTS2 | MCU | MCUB | MCUR1 | MDC1 | MDFI | MDFIC | MDGA1 | MDGA2 | MDH1 | MDH1B | MDH2 | MDK | MDM1 | MDM2 | MDM4 | MDN1 | MDS2 | ME1 | ME2 | ME3 | MEA1 | MEAF6 | MEAF6P1 | MEAK7 | Mechanoelectrical transducer (MET) channel | Mechanosensitive Ion Channel | MECOM | MECOM-AS1 | MeCP1 histone deacetylase (HDAC) complex | MECP2 | MECR | MED1 | MED10 | MED11 | MED12 | MED12L | MED13 | MED13L | MED14 | MED14P1 | MED15 | MED15P8 | MED16 | MED17 | MED18 | MED19 | MED20 | MED21 | MED22 | MED23 | MED24 | MED25 | MED26 | MED27 | MED28 | MED29 | MED30 | MED31 | MED4 | MED4-AS1 | MED6 | MED7 | MED8 | MED9 | MEDAG | Mediator Complex | Mediator of RNA Polymerase II Transcription | MEF2A | MEF2B | MEF2C